• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Biomarkers of cell death applicable to early clinical trials.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Dean, Emma J
    Greystoke, Alastair
    Ranson, Malcolm R
    Dive, Caroline
    Affiliation
    Paterson Institute for Cancer Research, The University of Manchester, Withington, Manchester, UK. edean@picr.man.ac.uk
    Issue Date
    2012-07-01
    
    Metadata
    Show full item record
    Abstract
    The development of biomarkers of cell death to reflect tumor biology and drug-induced response has garnered interest with the development of several classes of drugs aimed at decreasing the cellular threshold for apoptosis and exploiting pre-existing oncogenic stresses. These novel anticancer drugs, directly targeted to the apoptosis regulatory machinery and aimed at abrogating survival signaling pathways, are entering early clinical trials provoking the question of how to monitor their impact on cancer patients. The parallel development of drugs with predictive biomarkers and their incorporation into early clinical trials are anticipated to support the pharmacological audit trail, to speed the development and reduce the attrition rate of novel drugs whose objective is to provoke tumor cell death. Tumor biopsies are an ideal matrix to measure apoptosis, but surrogate less invasive biomarkers such as blood samples and functional imaging are less challenging to acquire clinically. Archetypal and exploratory examples illustrating the importance of biomarkers to drug development are given. This review explores the substantive challenges associated with the validation, deployment, interpretation and utility of biomarkers of cell death and reviews recent advances in their incorporation in preclinical and early clinical trial contexts.
    Citation
    Biomarkers of cell death applicable to early clinical trials. 2012, 318 (11):1252-9 Exp Cell Res
    Journal
    Experimental Cell Research
    URI
    http://hdl.handle.net/10541/240460
    DOI
    10.1016/j.yexcr.2012.03.020
    PubMed ID
    22483936
    Type
    Article
    Language
    en
    ISSN
    1090-2422
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.yexcr.2012.03.020
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Parallel anticancer drug development and molecular stratification to qualify predictive biomarkers: dealing with obstacles hindering progress.
    • Authors: Garcia VM, Cassier PA, de Bono J
    • Issue date: 2011 Aug
    • Pharmacodynamic biomarkers for molecular cancer therapeutics.
    • Authors: Sarker D, Workman P
    • Issue date: 2007
    • From darkness to light with biomarkers in early clinical trials of cancer drugs.
    • Authors: Carden CP, Banerji U, Kaye SB, Workman P, de Bono JS
    • Issue date: 2009 Feb
    • Biomarker-driven early clinical trials in oncology: a paradigm shift in drug development.
    • Authors: Tan DS, Thomas GV, Garrett MD, Banerji U, de Bono JS, Kaye SB, Workman P
    • Issue date: 2009 Sep-Oct
    • Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL.
    • Authors: Leong S, McKay MJ, Christopherson RI, Baxter RC
    • Issue date: 2012 Feb 3
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.